575 MADISON AVENUE, NEW YORK, NY
Financial Results, Press Release
Director Retirement - Zachary Prensky to Step Down from Board
Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
Announces $100.0 Million Private Placement
LB Pharmaceuticals Inc Enters Lease Amendment for Expansion Premises
Appoints Kaya Pai Panandiker as Chief Commercial Officer
Reports 3Q 2025 Financial Results and Recent Corporate Updates
News, Articles of Incorporation
Q3
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Registration of Securities
Amended Registration Statement for Securities
No filings found
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
S-1MEF